Page last updated: 2024-12-09
camphanic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
camphanic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 565594 |
| SCHEMBL ID | 1665205 |
| MeSH ID | M0485285 |
Synonyms (13)
| Synonym |
|---|
| 2-bornanecarboxylic acid |
| camphanic acid |
| camphancarbonsaeure |
| camphancarbonsaeure [german] |
| 1,7,7-trimethylbicyclo(2.2.1)heptanecarboxylic acid |
| bornanecarboxylic acid |
| niosh/dt5010000 |
| bicyclo(2.2.1)heptanecarboxylic acid, 1,7,7-trimethyl- |
| DT50100000 |
| AKOS016035589 |
| SCHEMBL1665205 |
| 1,7,7-trimethylbicyclo[2.2.1]heptane-2-carboxylic acid # |
| 1,7,7-trimethylbicyclo[2.2.1]heptane-2-carboxylic acid |
Research Excerpts
Effects
| Excerpt | Reference | Relevance |
|---|---|---|
| "Camphanic acid chloride has proven to be an efficient chiral derivatization reagent for determination of stereoisomers." | ( Camphanic acid chloride: a powerful derivatization reagent for stereoisomeric separation and its DMPK applications. Bowen, CL; Evans, CA; Fang, K; Licea-Perez, H; Rodgers, C; Szapacs, M; Wang, S, 2015) | 3.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 37.94
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (37.94) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||